Their bioinformatics analyses and experimental data found that SLC39A1 knockdown suppressed the expression of cyclin D1, MMP2, Wnt3A, and β-catenin and subsequently inhibited HCC progression. This evidence concerns the gene SLC39A1 and hepatocellular carcinoma.